Label: information for the user
Risperidone Viatris 4 mg film-coated tablets EFG
Read this label carefully before starting to take this medication, as it contains important information for you.
1. What is Risperidone Viatris and how it is used
2. What you need to know before starting to take Risperidone Viatris
3. How to take Risperidone Viatris
4. Possible adverse effects
5. Storage of Risperidone Viatris
6. Contents of the package and additional information
Risperidona belongs to a group of medications called “anti-psychotics”.
Risperidona is used to treat the following:
- Short-term treatment (up to 6 weeks) of prolonged aggression in intellectually disabled children (over 5 years) and adolescents with behavioral disorders.
Do not take Risperidona Viatris:
Warnings and precautions
Consult your doctor or pharmacist before taking Risperidona Viatris:
If you are unsure whether this applies to you, consult your doctor or pharmacist before taking risperidone.
During treatment
Risperidone may cause changes in the number of white blood cells, which help fight infections, so your doctor may perform blood tests before and after treatment.
Risperidone may cause weight gain. Significant weight gain can negatively affect your health. Your doctor should regularly measure your body weight.
Risperidone has been associated with diabetes or worsening of pre-existing diabetes in patients taking risperidone, so your doctor should check your blood sugar levels. Patients with pre-existing diabetes should regularly control their blood sugar (glucose) levels.
Risperidone increases prolactin hormone levels, which can cause adverse effects such as menstrual disorders or fertility problems in women or breast enlargement in men (see Possible Adverse Reactions). If these adverse effects appear, it is recommended to evaluate your prolactin blood levels.
If you are undergoing eye surgery, inform your doctor or hospital staff that you are taking this medication. During cataract surgery (a clouding of the lens in the eye), this medication may affect the pupil or iris (colored part of the eye), which could cause eye damage.
Patients with advanced age and dementia
In patients with advanced age and dementia, there is an increased risk of embolism or mini-embolism (also known as transient ischemic attack or TIA). Do not take risperidone if you have dementia caused by an embolism.
During treatment with risperidone, you should visit your doctor frequently.
You should seek immediate medical attention if you or your caregiver notice a sudden change in your mental state, sudden weakness, numbness in the face, arms, or legs, especially on one side, vision problems, or difficulty speaking, even if only for a short period. These may be signs of an embolism.
Children and adolescents
Before starting treatment for conduct disorder, other possible causes of aggressive behavior should be ruled out.
Before starting treatment, your body weight or your child's body weight may be measured and regularly monitored during treatment.
If during treatment you experience fatigue, a change in dosage time may improve attention difficulties.
A small, inconclusive study has reported an increase in height in children taking risperidone, but it is unknown whether this is a medication effect or due to another reason.
Taking Risperidona Viatris with other medications
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication, including over-the-counter medications and herbal remedies.
It is especially important to inform your doctor or pharmacist if you are taking any of the following medications:
The following medications reduce the effect of risperidone:
If you start or stop taking these medications, you may need a different dose of risperidone.
The following medications increase the effect of risperidone:
If you start or stop taking these medications, you may need a different dose of risperidone.
If you are unsure whether this applies to you, consult your doctor or pharmacist before taking risperidone.
Taking Risperidona Viatris with food, drinks, and alcohol
You should avoid consuming alcoholic beverages during treatment with risperidone.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. Your doctor will decide if you can take it.
The following symptoms may appear in newborns of mothers who have taken risperidone in the last trimester (the last three months of pregnancy): tremors, muscle stiffness, agitation, difficulty breathing, and difficulty feeding. If your baby shows any of these symptoms, you may need to contact your doctor.
Risperidone may increase prolactin hormone levels, which can affect fertility (see section 4, "Possible Adverse Reactions").
Driving and using machines
During treatment with risperidone, you may experience dizziness, fatigue, and vision problems. Do not drive or operate tools or machines without consulting your doctor first.
Risperidona Viatris contains lactose
If your doctor has told you that you have intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Risperidona Viatris 2 mg and 6 mgcontainsyellow orange
This medication may cause allergic reactions because it contains yellow orange (E110). It may cause asthma, especially in patients allergic to aspirin.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will tell you how much to take and for how long. This depends on your condition and varies from person to person.
The recommended dose is as follows:
For the treatment of schizophrenia
Adults
Older adults
Use in children and adolescents
For the treatment of mania
Adults
Older adults
Use in children and adolescents
For the treatment of prolonged aggression in patients with Alzheimer's disease
Adults (including older adults)
For the treatment of behavioral disorders in children and adolescents
The dose will depend on the child's weight:
For children weighing less than 50 kg:
For children weighing 50 kg or more:
Treatment in patients with behavioral disorders should not be prolonged for more than 6 weeks.
Children under 5 years old should not be treated with risperidone for behavioral disorders.
Patients with kidney or liver problems
Regardless of why you are taking this medication, all initial and subsequent doses should be reduced by half. The increase in dose should be slower in these patients.
Risperidone should be used with caution in this group of patients.
How to take risperidone
The tablet can be divided into equal doses.
If you take more Risperidona Viatris than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
In case of overdose, you may feel drowsy or tired, have abnormal body movements, have trouble standing or walking, feel dizzy due to low blood pressure, or experience a rapid or abnormal heart rate or seizures.
If you forget to take Risperidona Viatris
If you interrupt treatment with Risperidona Viatris
You should not stop taking this medication unless your doctor tells you to. It is possible that symptoms will reappear. If your doctor decides to stop treatment, the dose should be gradually reduced over a few days.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Consult your doctoror go to the emergency department of a hospitalimmediately if:
Frequent (can affect up to 1 in 10 people):
Infrequent (can affect up to 1 in 100 people):
Rare (can affect up to 1 in 1,000 people):
Very rare (can affect up to 1 in 10,000 people):
Consult your doctor immediately if you experience any of the side effects described above.
The following side effects may also occur:
Very frequent (can affect more than 1 in 10 people):
Frequent (can affect up to 1 in 10 people):
Infrequent (can affect up to 1 in 100 people):
Rare (can affect up to 1 in 1,000 people):
There have also been reports of low blood pressure when standing up with risperidone, which is associated with a very high increase in heart rate.
Other side effects in children and adolescents
In general, it is expected that side effects in children will be similar to those that appeared in adults.
The following side effects were reported more frequently in children and adolescents (5 to 17 years) than in adults: feeling drowsy or less attentive, fatigue (tiredness), headache, increased appetite, vomiting, common cold symptoms, nasal congestion, abdominal pain, dizziness, cough, fever, tremor (shaking), diarrhea and urinary incontinence.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medicationafter the expiration date that appears on the blister pack and on the container after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.Once the bottle is opened, use within 180 days.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Risperidona Viatris
The active ingredient is risperidone. Each film-coated tablet contains 4 mg of risperidone.
The other components are:
Core tablet:Lactose monohydrate, pregelatinized cornstarch, microcrystalline cellulose (E-460), magnesium stearate, anhydrous colloidal silica, sodium lauryl sulfate.
Coating:: Hypromellose (E-464), propylene glycol (E-490), titanium dioxide (E-171), talc (E-553B), yellow quinoline (E-104), indigo carmine (E-132).
Appearance of the product and contents of the package
Green, round, biconvex, film-coated tablet, marked with a “4”on one face and a notch on the other face.
Packaging sizes
Blister packs containing 20, 28, 30, 50, 56, 60 or 100 film-coated tablets.
Single-dose perforated blister packs containing (28×1), (30×1), (56×1), (60×1) or (100×1) film-coated tablets.
Bottles containing 30, 60, 100 or 250 film-coated tablets.
Only some packaging sizes may be marketed.
Marketing authorization holder andmanufacturer
Marketing authorization holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
McDermott Laboratories Limited t/a Gerard Laboratories
35/36 Baldoyle Industrial Estate,
Grange Road, Dublin 13.
Ireland
or
Mylan Hungary Kft.
Mylan utca 1
H-2900 Komárom
Hungary
or
Mylan Dublin
Newenham Court
Northern Cross
Malahide Road
Dublin 17
Ireland
or
Logiters, Logistica Portugal, S.A.
Estrada dos Arneiros, 4
Azambuja, 2050-306
Portugal
or
Mylan Germany GmbH
Zweigniederlassung Bad Homburg Benzstrasse 1,
61352 Bad Homburg v. d. Höhe,
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medication is authorized in the member states of the European Economic Area with the following names:
Germany: Risperidon Mylan 4 mg filmtabletten
Spain: Risperidona Viatris 4 mg film-coated tablets EFG
France: Risperidone Viatris 4 mgfilm-coated tablet
Italy: Risperidone Mylan Pharma
Portugal: Risperidona Mylan 4 mg film-coated tablet
Last review date of this leaflet:July 2019
The detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) https://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.